Of note, CD200 MFI < 189.5 was shown to retain its prognostic value in Binet A stage CLL patients, suggesting CD200 MFI < 189.5 as a significant risk factor in patients with early-stage disease. The gene discussed is CD200; the disease is B-cell chronic lymphocytic leukemia.